サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
市場調査レポート
商品コード
1402532

中南米の肺がんスクリーニング市場、2030年までの予測：地域別分析 - がんタイプ、技術、年齢層、エンドユーザー別

South & Central America Lung Cancer Screening Market Forecast to 2030 - Regional Analysis- by Cancer Type, Technology, Age Group (50 & Older and Below 50), and End User (Hospitals, Diagnostic Centers, and Others)
出版日: | 発行: The Insight Partners | ページ情報: 英文 100 Pages | 納期: 即納可能 即納可能とは

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.58円
中南米の肺がんスクリーニング市場、2030年までの予測：地域別分析 - がんタイプ、技術、年齢層、エンドユーザー別
出版日: 2023年11月07日
発行: The Insight Partners
ページ情報: 英文 100 Pages
納期: 即納可能 即納可能とは
  • 全表示
  • 概要
  • 図表
  • 目次
概要

中南米の肺がんスクリーニング市場は、2022年の3,916万米ドルから2030年には6,895万米ドルに成長すると予測されます。2022年から2030年までのCAGRは7.3%と推定されます。

肺がんスクリーニング検査費用の高さが中南米の肺がんスクリーニング市場に拍車をかける。

同地域でヘルスケア意識が高まる中、同地域の肺がんスクリーニングプロバイダーには十分な機会があります。これには、地域の病院や診療所と連携することで、アクセスしやすい肺がんスクリーニングを提供したり、遠隔地の遠隔医療を活用したりすることが含まれます。このアプローチは肺がんを早期に発見するだけでなく、患者の転帰を改善し、この地域のヘルスケアにおける重要なギャップを埋める。予防医療に対する需要の高まりに合わせることで、これらのプロバイダーは有望な市場に足場を築くことができ、最終的には地域全体の公衆衛生と福祉の向上に貢献することができます。

中南米の肺がんスクリーニング市場概要

中南米の肺がんスクリーニング市場は、ブラジル、アルゼンチン、その他中南米に区分されます。この地域の成長は、肺がん罹患率の増加や人々の肺がんスクリーニングに対する意識の高まりなど、さまざまな要因によるものです。また、検診に対する政府支援の高まりが市場のさらなる成長につながっています。

肺がんスクリーニング市場は、がんの有病率の増加などの要因によって影響を受けています。例えば、Globocan 2020の報告書によると、肺がんはブラジルで2番目に罹患率の高いがんです。ブラジルで新たに発見された肺がん症例は88492例でした。

肺がんスクリーニングは世界的に標準治療とされています。ブラジルでは、医療システムの組織、CTスキャンや治療法へのアクセス、文化的な受容などに関連する複雑な問題が、その実施プロセスを制限しています。現地の組織に従って検診を実施するには課題や障壁があるが、すべてのシナリオで満足のいく結果を得ることが可能でした。

Lung Cancer Policy Networkによると、ブラジルでは、肺がんスクリーニングに対する協調的なアプローチが必要です。LDCT検診の利点は、第2回ブラジル早期肺がんスクリーニング試験（BRELT2）で最近報告されました。とはいえ、組織化された検診プログラムを全国的に実施するには、公的ヘルスケアと民間ヘルスケアとの間で検診機器へのアクセスが不平等であるなど、克服すべき障壁がまだ多くあります。この課題に対処するため、Propulmao Mobile Projectの一環として、バレトス（サンパウロ）の市保健局は地元のがん病院と協力し、移動式LDCT検診と禁煙介入を地域で実施しました。

中南米の肺がんスクリーニング市場の収益と2030年までの予測（金額）

中南米の肺がんスクリーニング市場セグメンテーション

中南米の肺がんスクリーニング市場は、がん種、技術、年齢層、エンドユーザー、国別に区分されます。

がんの種類に基づき、中南米の肺がんスクリーニング市場は非小細胞肺がん（NSCLC）と小細胞肺がんに区分されます。2022年の中南米の肺がんスクリーニング市場では、非小細胞肺がん（NSCLC）セグメントが大きなシェアを占めています。

技術に基づき、中南米の肺がんスクリーニング市場は胸部X線、低線量コンピュータ断層撮影（LDCT）、リキッドバイオプシー、その他に区分されます。2022年の中南米の肺がんスクリーニング市場では、胸部X線部門が最大のシェアを占めています。

年齢層に基づき、中南米の肺がんスクリーニング市場は50歳以上と50歳未満に区分されます。50歳以上セグメントは2022年に中南米の肺がんスクリーニング市場でより大きなシェアを占めました。

エンドユーザーに基づき、中南米の肺がんスクリーニング市場は病院、診断センター、その他に区分されます。病院セグメントが2022年の中南米の肺がんスクリーニング市場で最大のシェアを占めました。

国別では、中南米の肺がんスクリーニング市場はブラジル、アルゼンチン、その他南米に区分されます。2022年の中南米の肺がんスクリーニング市場はブラジルが支配的。

Siemens AG、Koninklijke Philips NV、Canon Inc、Medtronic、GE HealthCare technologies Incは、南米・中米の肺がんスクリーニング市場で事業を展開する大手企業です。

目次

目次

第1章 イントロダクション

第2章 中南米の肺がんスクリーニング市場：要点

第3章 調査手法

  • 調査範囲
  • 2次調査
  • 1次調査

第4章 中南米の肺がんスクリーニング市場：市場展望

  • 中南米のPEST分析
  • 専門家の見解

第5章 中南米の肺がんスクリーニング市場：主要市場力学

  • 市場促進要因
    • 肺がん罹患率の上昇
  • 市場抑制要因
    • 肺がんスクリーニング検査の高コスト
  • 市場機会
    • 地域の病院やクリニックとの連携
  • 今後の動向
    • 最先端技術の利用
  • インパクト分析

第6章 肺がんスクリーニング市場：中南米分析

  • 中南米の肺がんスクリーニング市場収益と予測分析

第7章 中南米の肺がんスクリーニング市場-2028年までの収益と予測：がんタイプ別

  • 非小細胞肺がん（NSCLC）
  • 小細胞肺がん

第8章 中南米の肺がんスクリーニング市場分析：技術別

  • 低線量コンピュータ断層撮影（LDCT）
  • 胸部X線検査
  • リキッドバイオプシー
  • その他

第9章 中南米の肺がんスクリーニング市場分析：年齢層別

  • 50歳以上
  • 50歳未満

第10章 中南米の肺がんスクリーニング市場分析：エンドユーザー別

  • 病院
  • 診断センター
  • その他

第11章 中南米の肺がんスクリーニング市場-2028年までの収益と予測：国別分析

  • 中南米の肺がんスクリーニング市場概要

第12章 中南米の肺がんスクリーニング市場-業界情勢

  • 最近の成長戦略

第13章 企業プロファイル企業プロファイル

  • Nuance Communications Inc
  • GE HealthCare
  • Medtronic
  • Canon Inc.
  • Koninklijke Philips NV
  • Siemens AG

第14章 付録

図表

List Of Tables

List of Tables

  • Table 1. Brazil South & Central America Lung Cancer Screening Market, by Cancer Type - Revenue and Forecast to 20228 (US$ Million)
  • Table 2. Brazil South & Central America Lung Cancer Screening Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
  • Table 3. Brazil South & Central America Lung Cancer Screening Market, by Age Group - Revenue and Forecast to 2030 (US$ Million)
  • Table 4. Brazil South & Central America Lung Cancer Screening Market, by End User - Revenue and Forecast to 2030 (US$ Million)
  • Table 5. Argentina South & Central America Lung Cancer Screening Market, by Cancer Type - Revenue and Forecast to 20228 (US$ Million)
  • Table 6. Argentina South & Central America Lung Cancer Screening Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
  • Table 7. Argentina South & Central America Lung Cancer Screening Market, by Age Group - Revenue and Forecast to 2030 (US$ Million)
  • Table 8. Argentina South & Central America Lung Cancer Screening Market, by End User - Revenue and Forecast to 2030 (US$ Million)
  • Table 9. Rest of South & Central America Lung Cancer Screening Market, by Cancer Type - Revenue and Forecast to 20228 (US$ Million)
  • Table 10. Rest of South & Central America Lung Cancer Screening Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
  • Table 11. Rest of South & Central America Lung Cancer Screening Market, by Age Group - Revenue and Forecast to 2030 (US$ Million)
  • Table 12. Rest of South & Central America Lung Cancer Screening Market, by End User - Revenue and Forecast to 2030 (US$ Million)
  • Table 13. Recent Growth Strategies in the South & Central America Lung Cancer Screening Market
  • Table 14. Glossary of Terms

List Of Figures

List of Figures

  • Figure 1. South & Central America Lung Cancer Screening Market Segmentation
  • Figure 2. South & Central America Lung Cancer Screening Market, by Country
  • Figure 3. South & Central America Lung Cancer Screening Market Overview
  • Figure 4. Non-Small Cell Lung Cancer Segment Held Largest Share of Cancer Type Segment in South & Central America Lung Cancer Screening Market
  • Figure 5. South & Central America Expected to Show Remarkable Growth During Forecast Period
  • Figure 6. South & Central America: PEST Analysis
  • Figure 7. Experts' Opinion
  • Figure 8. South & Central America Lung Cancer Screening Market Impact Analysis of Driver and Restraints
  • Figure 9. South & Central America Lung Cancer Screening Market - Revenue Forecast and Analysis - 2020-2030
  • Figure 10. South & Central America Lung Cancer Screening Market Revenue Share, by Cancer Type 2022 & 2030 (%)
  • Figure 11. Non-Small Cell Lung Cancer (NSCLC): South & Central America Lung Cancer Screening Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 12. Small Cell Lung Cancer: South & Central America Lung Cancer Screening Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 13. South & Central America Lung Cancer Screening Market, by Technology, 2022 & 2030 (%)
  • Figure 14. Low-Dose Computed Tomography (LDCT): South & Central America Lung Cancer Screening Market- Revenue and Forecast to 2030 (US$ Million)
  • Figure 15. Chest X-ray: South & Central America Lung Cancer Screening Market- Revenue and Forecast to 2030 (US$ Million)
  • Figure 16. Liquid Biopsy: South & Central America Lung Cancer Screening Market- Revenue and Forecast to 2030 (US$ Million)
  • Figure 17. Others: South & Central America Lung Cancer Screening Market- Revenue and Forecast to 2030 (US$ Million)
  • Figure 18. South & Central America Lung Cancer Screening Market, by Age group, 2022 & 2030 (%)
  • Figure 19. & Older: South & Central America Lung Cancer Screenings Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 20. Below 50: Lung Cancer Screenings Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 21. South & Central America Lung Cancer Screening Market, by End User, 2022 & 2030 (%)
  • Figure 22. Hospitals: Lung Cancer Screenings Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 23. Diagnostic Centers: Lung Cancer Screenings Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 24. Others: Lung Cancer Screenings Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 25. South & Central America Lung Cancer Screening Market, by Key Country - Revenue (2022) (US$ Mn)
  • Figure 26. South & Central America Lung Cancer Screening Market Revenue Share, by Key Country (2022 and 2030)
  • Figure 27. Brazil: South & Central America Lung Cancer Screening Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 28. Argentina: South & Central America Lung Cancer Screening Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 29. Rest of South & Central America: South & Central America Lung Cancer Screening Market - Revenue and Forecast to 2030 (US$ Million)
目次
Product Code: BMIRE00029065

The South & Central America lung cancer screening market is expected to grow from US$ 39.16 million in 2022 to US$ 68.95 million by 2030. It is estimated to grow at a CAGR of 7.3% from 2022 to 2030.

High cost of lung cancer screening tests fuel South & Central America lung cancer screening market.

Amid growing healthcare awareness in the region, lung cancer screening providers in the region has ample opportunities. These include collaborating with regional hospitals and clinics through which they can offer accessible lung cancer screening and leveraging telemedicine for remote areas. This approach not only detects lung cancer early but also improves patient outcomes, filling a crucial gap in the region's healthcare. By aligning with the rising demand for preventive care, these providers can establish a foothold in a promising market, ultimately contributing to enhanced public health and well-being across the region.

South & Central America Lung Cancer Screening Market Overview

The South & Central America lung cancer screening market is segmented into the Brazil, Argentina, and the Rest of South & Central America. The regional growth is attributed to various factors, such as the increasing incidence of lung cancer and growing awareness of lung cancer screening among people. Also, rising government support for screening has led to the further growth of the market.

The lung cancer screening market is being influenced by factors such as the increasing prevalence of cancer. For instance, as per Globocan 2020 report, lung cancer is Brazil's second most prevalent cancer. There were 88492 new cases of lung cancer found in Brazil.

Lung cancer screening is believed to be the standard of care worldwide. In Brazil, complications in its implementation related to the organization of the health system, access to CT scans and treatment methods, and cultural acceptance of the method restrict the process. There are challenges and barriers in carrying out the screening according to the local organization; however, it was possible to obtain satisfactory results in all scenarios.

According to Lung Cancer Policy Network, In Brazil, a coordinated approach to lung cancer screening is necessary, as health assistance is fragmented across the country and has resulted in significant health inequalities. The advantages of LDCT screening were recently described in the Second Brazilian Early Lung Cancer Screening Trial (BRELT2). Nevertheless, there are still many barriers to overcome before an organized screening program can be implemented nationwide, including inequitable access to screening equipment between public and private healthcare. To manage this challenge, as part of the Propulmao Mobile Project, the municipal health office in Barretos (Sao Paulo) collaborated with the local cancer hospital to deliver mobile LDCT screening and a smoking cessation intervention in the community.

South & Central America Lung Cancer Screening Market Revenue and Forecast to 2030 (US$ Million)

South & Central America Lung Cancer Screening Market Segmentation

The South & Central America lung cancer screening market is segmented into cancer type, technology, age group, end user, and country.

Based on cancer type, the South & Central America lung cancer screening market is segmented into non-small cell lung cancer (NSCLC), and small cell lung cancer. The non-small cell lung cancer (NSCLC) segment held a larger share of the South & Central America lung cancer screening market in 2022.

Based on technology, the South & Central America lung cancer screening market is segmented into chest X-ray, low dose computed tomography (LDCT), liquid biopsy, and others. Chest X-ray segment held the largest share of the South & Central America lung cancer screening market in 2022.

Based on age group, the South & Central America lung cancer screening market is segmented into 50 and older, and below 50. 50 and older segment held the larger share of the South & Central America lung cancer screening market in 2022.

Based on end user, the South & Central America lung cancer screening market is segmented into hospital, diagnostic centre, and others. Hospital segment held the largest share of the South & Central America lung cancer screening market in 2022.

Based on country, the South & Central America lung cancer screening market is segmented into Brazil, Argentina, and the Rest of South & Central America. Brazil dominated the South & Central America lung cancer screening market in 2022.

Siemens AG, Koninklijke Philips NV, Canon Inc, Medtronic, and GE HealthCare technologies Inc are some of the leading companies operating in the South & Central America lung cancer screening market.

Reasons to Buy:

  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the South & Central America Lung Cancer Screening Market.
  • Highlights key business priorities in order to assist companies to realign their business strategies.
  • The key findings and recommendations highlight crucial progressive industry trends in South & Central America Lung Cancer Screening Market, thereby allowing players across the value chain to develop effective long-term strategies.
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
  • Scrutinize in-depth South & Central America Market trends and outlook coupled with the factors driving the market, as well as those hindering it.
  • Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.

Table Of Contents

Table of Contents

1. Introduction

  • 1.1 Study Scope
  • 1.2 The Insight Partners Research Report Guidance
  • 1.3 Market Segmentation
    • 1.3.1 South & Central America Lung Cancer Screening Market - by Technology
    • 1.3.2 South & Central America Lung Cancer Screening Market - by Cancer Type
    • 1.3.3 South & Central America Lung Cancer Screening Market - by Age Group
    • 1.3.4 South & Central America Lung Cancer Screening Market - by End User
    • 1.3.5 South & Central America Lung Cancer Screening Market - by Country

2. South & Central America Lung Cancer Screening Market - Key Takeaways

3. Research Methodology

  • 3.1 Coverage
  • 3.2 Secondary Research
  • 3.3 Primary Research

4. South & Central America Lung Cancer Screening Market - Market Landscape

  • 4.1 Overview
  • 4.2 South & Central America PEST Analysis
  • 4.3 Expert's Opinion

5. South & Central America Lung Cancer Screening Market - Key Market Dynamics

  • 5.1 Market Drivers
    • 5.1.1 Rising Lung Cancer Incidences
  • 5.2 Market Restraints
    • 5.2.1 High Cost of Lung Cancer Screening Tests
  • 5.3 Market Opportunities
    • 5.3.1 Collaboration with Regional Hospitals and Clinics
  • 5.4 Future Trends
    • 5.4.1 Use of Cutting-Edge Technologies
  • 5.5 Impact Analysis

6. Lung Cancer Screening Market - South & Central America Analysis

  • 6.1 South & Central America Lung Cancer Screening Market Revenue Forecast and Analysis

7. South & Central America Lung Cancer Screening Market - Revenue and Forecast to 2028 - By Cancer Type

  • 7.1 Overview
  • 7.2 South & Central America Lung Cancer Screening Market Revenue Share, by Cancer Type 2022 & 2030 (%)
  • 7.3 Non-Small Cell Lung Cancer (NSCLC)
    • 7.3.1 Overview
    • 7.3.2 Non-Small Cell Lung Cancer (NSCLC): South & Central America Lung Cancer Screening Market - Revenue and Forecast to 2030 (US$ Mn)
  • 7.4 Small Cell Lung Cancer
    • 7.4.1 Overview
    • 7.4.2 Small Cell Lung Cancer: South & Central America Lung Cancer Screening Market - Revenue and Forecast to 2030 (US$ Million)

8. South & Central America Lung Cancer Screening Market Analysis - by Technology

  • 8.1 Overview
  • 8.2 Low-Dose Computed Tomography (LDCT)
    • 8.2.1 Overview
    • 8.2.2 Low-Dose Computed Tomography (LDCT): South & Central America Lung Cancer Screening Market- Revenue and Forecast to 2030 (US$ Million)
  • 8.3 Chest X-ray
    • 8.3.1 Overview
    • 8.3.2 Chest X-ray: South & Central America Lung Cancer Screening Market- Revenue and Forecast to 2030 (US$ Million)
  • 8.4 Liquid Biopsy
    • 8.4.1 Overview
    • 8.4.2 Liquid Biopsy: South & Central America Lung Cancer Screening Market- Revenue and Forecast to 2030 (US$ Million)
  • 8.5 Others
    • 8.5.1 Overview
    • 8.5.2 Others: South & Central America Lung Cancer Screening Market- Revenue and Forecast to 2030 (US$ Million)

9. South & Central America Lung Cancer Screening Market Analysis - by Age Group

  • 9.1 Overview
  • 9.2 & Older
    • 9.2.1 Overview
    • 9.2.2 & Older: South & Central America Lung Cancer Screenings Market - Revenue and Forecast to 2030 (US$ Million)
  • 9.3 Below 50
    • 9.3.1 Overview
    • 9.3.2 Below 50: Lung Cancer Screenings Market - Revenue and Forecast to 2030 (US$ Million)

10. South & Central America Lung Cancer Screening Market Analysis - by End User

  • 10.1 Overview
  • 10.2 Hospitals
    • 10.2.1 Overview
    • 10.2.2 Hospitals: Lung Cancer Screenings Market - Revenue and Forecast to 2030 (US$ Million)
  • 10.3 Diagnostic Centers
    • 10.3.1 Overview
    • 10.3.2 Diagnostic Centers: Lung Cancer Screenings Market - Revenue and Forecast to 2030 (US$ Million)
  • 10.4 Others
    • 10.4.1 Overview
    • 10.4.2 Others: Lung Cancer Screenings Market - Revenue and Forecast to 2030 (US$ Million)

11. South & Central America Lung Cancer Screening Market - Revenue and Forecast to 2028 - Country Analysis

  • 11.1 South & Central America Lung Cancer Screening Market Overview
      • 11.1.1.1 Brazil: South & Central America Lung Cancer Screening Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.1.1.1.1 Overview
        • 11.1.1.1.2 Brazil: South & Central America Lung Cancer Screening Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.1.1.1.3 Brazil: South & Central America Lung Cancer Screening Market, by Cancer Type, 2020-2030 (US$ Million)
        • 11.1.1.1.4 Brazil: South & Central America Lung Cancer Screening Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
        • 11.1.1.1.5 Brazil: South & Central America Lung Cancer Screening Market, by Age Group, 2020-2030 (US$ Million)
        • 11.1.1.1.6 Brazil: South & Central America Lung Cancer Screening Market, by End User, 2020-2030 (US$ Million)
      • 11.1.1.2 Argentina: South & Central America Lung Cancer Screening Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.1.1.2.1 Overview
        • 11.1.1.2.2 Argentina: South & Central America Lung Cancer Screening Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.1.1.2.3 Argentina: South & Central America Lung Cancer Screening Market, by Cancer Type, 2020-2030 (US$ Million)
        • 11.1.1.2.4 Argentina: South & Central America Lung Cancer Screening Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
        • 11.1.1.2.5 Argentina: South & Central America Lung Cancer Screening Market, by Age Group, 2020-2030 (US$ Million)
        • 11.1.1.2.6 Argentina: South & Central America Lung Cancer Screening Market, by End User, 2020-2030 (US$ Million)
      • 11.1.1.3 Rest of South & Central America: South & Central America Lung Cancer Screening Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.1.1.3.1 Overview
        • 11.1.1.3.2 Rest of South & Central America: South & Central America Lung Cancer Screening Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.1.1.3.3 Rest of South & Central America: South & Central America Lung Cancer Screening Market, by Cancer Type, 2020-2030 (US$ Million)
        • 11.1.1.3.4 Rest of South & Central America: South & Central America Lung Cancer Screening Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
        • 11.1.1.3.5 Rest of South & Central America: South & Central America Lung Cancer Screening Market, by Age Group, 2020-2030 (US$ Million)
        • 11.1.1.3.6 Rest of South & Central America: South & Central America Lung Cancer Screening Market, by End User, 2020-2030 (US$ Million)

12. South & Central America Lung Cancer Screening Market-Industry Landscape

  • 12.1 Recent Growth Strategies
    • 12.1.1 Overview

13. Company Profiles

  • 13.1 Nuance Communications Inc
    • 13.1.1 Key Facts
    • 13.1.2 Business Description
    • 13.1.3 Products and Services
    • 13.1.4 Financial Overview
    • 13.1.5 SWOT Analysis
    • 13.1.6 Key Developments
  • 13.2 GE HealthCare
    • 13.2.1 Key Facts
    • 13.2.2 Business Description
    • 13.2.3 Products and Services
    • 13.2.4 Financial Overview
    • 13.2.5 SWOT Analysis
    • 13.2.6 Key Developments
  • 13.3 Medtronic
    • 13.3.1 Key Facts
    • 13.3.2 Business Description
    • 13.3.3 Products and Services
    • 13.3.4 Financial Overview
    • 13.3.5 SWOT Analysis
    • 13.3.6 Key Developments
  • 13.4 Canon Inc.
    • 13.4.1 Key Facts
    • 13.4.2 Business Description
    • 13.4.3 Products and Services
    • 13.4.4 Financial Overview
    • 13.4.5 SWOT Analysis
    • 13.4.6 Key Developments
  • 13.5 Koninklijke Philips NV
    • 13.5.1 Key Facts
    • 13.5.2 Business Description
    • 13.5.3 Products and Services
    • 13.5.4 Financial Overview
    • 13.5.5 SWOT Analysis
    • 13.5.6 Key Developments
  • 13.6 Siemens AG
    • 13.6.1 Key Facts
    • 13.6.2 Business Description
    • 13.6.3 Products and Services
    • 13.6.4 Financial Overview
    • 13.6.5 SWOT Analysis
    • 13.6.6 Key Developments

14. Appendix

  • 14.1 About The Insight Partners
  • 14.2 Glossary of Terms